T. C. Merigan

Medicine · Health Sciences

39h-index4.7kcitations112works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(25), HIV Research and Treatment(24), Herpesvirus Infections and Treatments(17), Cytomegalovirus and herpesvirus research(16), HIV/AIDS Research and Interventions(12)

Publications112 total

Murine monoclonal antibody to a si infectivity of human cytomegaloviri
2016
Interferon: An Immune-Specific or a Non-Specific Host Defense?1
2015
Detection and Qualification of Human Immunodeficiency Virus RNA in Patient Serum by Use of the Polymerase Chain Reaction
The Journal of Infectious Diseases·2004Open Access
Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
Antiviral Therapy·2002· 128 citedOpen Access
Superficial Mycoses and Dermatophytoses
2001· 2 cited
Clinical Resistance Patterns and Responses to Two Sequential Protease Inhibitor Regimens in Saquinavir and Reverse Transcriptase Inhibitor–Experienced Persons
The Journal of Infectious Diseases·1999· 60 citedOpen Access
Zidovudine Resistance Reverse Transcriptase Mutations during Didanosine Monotherapy
The Journal of Infectious Diseases·1996· 16 citedOpen Access
Multiple cerebral lesions complicating therapy with interleukin-2
Neurology·1996· 52 cited
Polyethylene Glycol-Modified Interleukin-2 and Thymosin  1 in Human Immunodeficiency Virus Type 1 Infection
The Journal of Infectious Diseases·1996· 20 citedOpen Access
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
Journal of Virology·1996· 247 citedOpen Access
Quantification of Human Cytomegalovirus DNA during Viremia identifies Risk for Retinitis in AIDS Patients
1996
The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases.
PubMed·1995· 51 cited
Drug Resistance and Heterogeneous Long-Term Virologic Responses of Human Immunodeficiency Virus Type 1-Infected Subjects to Zidovudine and Didanosine Combination Therapy
The Journal of Infectious Diseases·1995· 105 cited
Editorial: New Virologic Tools for the Design and Analysis of Clinical Trials
The Journal of Infectious Diseases·1995· 5 cited
AIDS 1995. Clinical treatment: overview.
PubMed·1995
Natural polymorphism of HIV-1 clade B protease gene and implications for therapy
Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory)·1995
Quantitation of Human Cytomegalovirus DNA from Peripheral Blood Cells of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis
Retina·1995· 1 cited
Detection Of Drug Resistance Mutations In The Human Immunodeficiency Virus Type I (HIV-I) pol Gene: Differences In Semen And Blood HIV-I RNA And Proviral DNA
The Journal of Infectious Diseases·1994· 62 cited
Failure Of Short-Term Cd4-Pe40 Infusions To Reduce Virus Load In Human Immunodeficiency Virus-Infected Persons
The Journal of Infectious Diseases·1994· 34 cited
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
PubMed·1994· 29 cited
page 1 of 6Next →

Frequent Co-authors

David Katzenstein(8), Mark A. Winters(6), Teresa Y. Basham(5), Mark Holodniy(5), Robert W. Shafer(3), Lucy Rasmussen(3), John W. Torseth(3), Astrid K. N. Iversen(2), Ronald Levy(2), John Huddlestone(2), Margaret A. Fischl(2), William G. Powderly(2), Richard B. Pollard(2), Kamal Hamed(2), Peter B. Gregory(2), Michael J. Kozal(2), José G. Montoya(2), David H. Schwartz(2), DA Amato(2), James Balsley(2)